Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery

		Keywords:		Vaccine, Daclizumab (Zenapax®-)

		Phase:		Phase 1/2

		Treatment ID#s:		VT1839 NCT00626015

		Age Group:		Adults Only

		Min Karnofsky Score:		80: Able to perform normal activity with effort; some signs and symptoms of disease

		Conditions:		Newly Diagnosed: Y Recurrent: N Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Zenapax®-Activated Peptide ImmunoTherapy [ZAP IT]

		Last Updated:		03/02/2008

		Tumor Types:		Glioblastoma Multiforme


		Comments:

		Treatment Type:		Chemotherapy Radiation Immunological, Biological or Targeted Therapy.

		Contact:		The Brain Tumor Center at Duke Henry Friedman, MD Contact: Dr. Henry S. Friedman Rm 047 Baker House, Hospital South Trent Drive Durham, NC 27710- Phone:(919)684-5301 Fax: (919)684-6674 Click here to send an email Website: www.cancer.duke.edu/btc

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By